Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

We performed a phase II study of combination chemotherapy with irinotecan, 5-fluorouracil (5-FU) and leucovorin in metastatic gastric cancer patients who were previously treated with taxane and cisplatin, to evaluate the antitumour activity and toxicity of the combination chemotherapy. The metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, S T, Kang, W K, Kang, J H, Park, K W, Lee, J, Lee, S-H, Park, J O, Kim, K, Kim, W S, Jung, C W, Park, Y S, Im, Y-H, Park, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361777/
https://www.ncbi.nlm.nih.gov/pubmed/15870718
http://dx.doi.org/10.1038/sj.bjc.6602575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361777/
https://www.ncbi.nlm.nih.gov/pubmed/15870718
http://dx.doi.org/10.1038/sj.bjc.6602575

Ejemplares similares